title: Optimization of a model of red blood cells for the study of anti-oxidant drugs, in terms of concentration of oxidant and phosphate buffer.
abstract: The aggression of erythrocytes by an oxidative stress induces hemolysis. This paper aims to valid a model of erythrocytes in terms of composition of the phosphate buffer solution and of concentration of a well-known oxidant, AAPH. Three compositions of phosphate buffer solution are mixed with three concentrations of oxidant. The influence of these two parameters on hemolysis is independently studied by a variance analysis and a Kruskal-Wallis test when ANOVA is not available. The hemolysis rate increases with time at fixed oxidant concentration, but is not influenced by the composition of the buffer solution. The highest hemolysis rate, 90%, was only measured within 2 h with the highest oxidant concentration. If we retain this concentration of oxidant, the lower concentration of the buffer can by eliminated by a significant less hemolysis and the highest concentration of the buffer can by chosen in regard of the better precision for a similar hemolysis compared to the mean buffer. We hope to study the effect of anti-oxidant agent with such a model of erythrocytes.
authors.affiliation: Laboratoire de Chimie Bio-Inorganique, Faculté de Pharmacie de Dijon, 7, boulevard Jeanne-d'Arc, 21079 Dijon, France. alainbureau@libertysurf.fr
authors.forename: A
authors.initials: A
authors.lastname: Bureau
authors.forename: J-J
authors.initials: JJ
authors.lastname: Lahet
authors.forename: F
authors.initials: F
authors.lastname: Lenfant
authors.forename: F
authors.initials: F
authors.lastname: Bouyer
authors.forename: M
authors.initials: M
authors.lastname: Petitjean
authors.forename: B
authors.initials: B
authors.lastname: Chaillot
authors.forename: M
authors.initials: M
authors.lastname: Freysz
mesh_terms: D000975:Antioxidants / Q000494:pharmacology*; D002021:Buffers; D004305:Dose-Response Relationship, Drug; D004912:Erythrocytes / Q000187:drug effects* / Q000378:metabolism; D006461:Hemolysis / Q000187:drug effects*; D006801:Humans; D009994:Osmolar Concentration; D016877:Oxidants / Q000494:pharmacology; D010710:Phosphates / Q000494:pharmacology
chemical_list: D000975:Antioxidants; D002021:Buffers; D016877:Oxidants; D010710:Phosphates